Restricted accessLetterFirst published online 2018-2
Do anti-neutrophil cytoplasmic antibodies play a role in systemic lupus erythematosus (SLE) patients? Analysis of the University College Hospital SLE cohort
NishiyaKChikazawaHNishimuraSHisakawaNHashimotoK. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol1997; 16: 70–75.
2.
MerkelPAPolissonRPChangYCSkatesSJNilesJL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med1997; 126: 866–873.
3.
WeinerMSegelmarkM. The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmunity2016; 15: 978–982.
4.
CsernokKDamoiseauxJRasmussenNet al.Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Autoimmun Rev2006; 15: 736–741.
5.
SavigeJGillisDBensonEet al.International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Path1999; 111: 507–513.
